Skip to main content
Conferences and Meetings 114. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Clinical and Epidemiological: Poster III

114. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Clinical and Epidemiological: Poster III

Short name: updated-114. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Clinical and Epidemiological: Poster III-2025 Annual Meeting Poster Bundle Erythroid Development & Iron Metabolism
Course start date: 02/05/2026

Sections

General
0 activities

Randomized controlled trial in progress of an interdisciplinary treatment program for youth with chronic SCD pain Integrative strong body and mind training for sickle cell disease I STRONG
Pilot of standardized cognitive behavioral therapy for young adults with sickle cell disease
Venous thromboembolism in adults with sickle cell disease A national inpatient sample analysis 2016–2020
Venous thromboembolism in adults with sickle cell disease A national inpatient sample analysis 2016–2020
Elevated d dimer predicts worse outcomes in hospitalized adults with sickle cell crisis A real world multicenter study
Investigation of predictive markers of disease complications in children with sickle cell disease Preliminary findings from a multicenter prospective inception cohort study
Influenza vaccine coverage effectiveness and disease burden among pediatric sickle cell patients in Connecticut from 2021 2024 A test negative case control study
Pregnancy related complications and placenta pathology in pregnant women with sickle cell disease
High accuracy transfusion aware machine learning pipeline for hemoglobin genotype classification with shap based interpretability
Cancer specific risk and mortality due to autoimmune hemolytic anemia AIHA associated with immune checkpoint inhibitors ICI
Healthcare transition readiness for sickle cell disease A high and low income comparative analysis
Raising pre transfusion HbS levels from 30 to 50 does not increase ischemic stroke recurrence in sickle cell disease Results from a long term single center study
Modified release formulation of decitabine and tetrahydrouridine combination not only increases exposure to decitabine but reduces exposure to unfavorable decitabine metabolites in healthy volunteers
Standard transcranial doppler as a resource efficient first step to screen for MRA defined cerebral vasculopathy in adults with sickle cell disease
Machine learning replicates and extends clinician informed disease severity grading classification for acute pain and CKD in sickle cell disease
Chronic kidney disease risk stratification in compound sickle cell disease variants A single center review
Efficacy and safety of osivelotor in participants with sickle cell disease in a 12 week phase 2 multicenter open label dose finding trial and extension study
Impact of obesity on inpatient outcomes in patients hospitalized with acute chest syndrome
Describing the feasibility and acceptability of an electronic adherence monitor to measure hydroxyurea adherence among youth with sickle cell disease
Bone mineral density findings in patients with sickle cell disease
Racial and socioeconomic disparities in transfusion utilization among hospitalized sickle cell disease patients An analysis of the 2022 national inpatient sample
Registration and characterization of patients with Glucose 6 Phosphate Dehydrogenase Deficiency in Spain A  real world study of the Spanish Erythropathology Group GEE
The psychometric properties of the stoplight pain scale in children with sickle cell disease
Association of low annexin A2 levels with venous thromboembolism in sickle cell anemia A potential biomarker
Impact of pain sensitization phenotypes on quality of life among adults with sickle cell disease
Rheological effects of voxelotor in SCD A double edged sword
Baseline data from the prioritizing utilization and safety of hydroxyurea using precision in Africa PUSHUP trial
Early weight gain predicts nutritional recovery in children with sickle cell anemia and severe acute malnutrition in Nigeria
Description of neurocognition in adult sickle cell disease patients using the NIH toolbox

Vimeo Vimeo
29